市場調查報告書
商品編碼
1463582
南美洲和中美洲牛診斷市場預測至 2030 年 - 區域分析 - 按產品、疾病類型和最終用戶(獸醫醫院、獸醫診所和其他最終用戶)South & Central America Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) |
南美洲和中美洲CAGR診斷市場預計將從2022年的1.1401億美元成長到2030年的1.7957億美元。
牛乳腺炎的高盛行率和經濟影響推動了南美洲和中美洲牛診斷市場
牛乳腺炎是一個全球性問題,對全球農業部門帶來巨大的經濟損失。乳腺炎會導致受影響動物的產奶量下降,並導致持續的獸醫費用,從而導致酪農的獲利能力下降。根據賽默飛世爾科技 2022 年 7 月發布的估計,乳腺炎每年對全球乳製品行業造成的總成本在 197 億美元至 320 億美元之間。
根據2021 年4 月發表的研究《全球和全國範圍內乳牛和水牛亞臨床和臨床乳房炎盛行率的系統性回顧和統合分析》,全球亞臨床乳房炎(SCM) 和臨床乳房炎(CM) 的匯總盛行率2011-2019 年期間分別為 42% 和 15%。由於乳製品行業中乳腺炎的歷史較長,預計乳腺炎的盛行率將會增加。來自世界各地的事實和資料表明臨床乳房炎的高盛行率,這引發了對牛診斷的需求。此外,不同國家政府引入的監測計劃和良好的管理系統支持了牛隻診斷市場。
南美洲和中美洲牛診斷市場概述
南美洲和中美洲的牛隻診斷市場分為巴西、阿根廷以及南美洲和中美洲的其他地區。該地區市場成長的主要推動因素包括牛隻診斷工具和技術的進步、口蹄疫和結核病發病率的增加、以及為提高含牛肉食品品質而進行的牛隻診斷的增加。巴西在南美洲和中美洲牛診斷市場中佔有最大佔有率。巴西是世界領先的畜牧業國家,飼養的牛隻數量最多。世界人口的成長和生活水準的提高推動了世界各地對肉類的需求。因此,對健康肉類的需求導致巴西牛診斷市場的成長。診斷技術的進步使得牛白血病病毒(BLV)的診斷和系統發育分析成為可能。巴西東北部馬拉尼昂州的乳牛中存在明顯的 BLV 感染,2022 年系統發育推斷首次顯示該地區存在基因型 6。該基因型與先前在巴西中西部和東南部樣本中發現的基因序列有關。因此,BLV 和 EBL 診斷的開發工作於 2022 年啟動,這推動了針對早期感染病例的白血病治療方案的進展。地方性牛白血病(EBL)是一種廣泛分佈於牛群的慢性病毒性疾病,可能需要數年時間才能顯現臨床症狀。因此,為了預防牛群中的流行病,診斷結果將使獸醫衛生當局和畜牧養殖者能夠採取初步行動。
南美洲和中美洲牛診斷市場收入及 2030 年預測(百萬美元)
南美洲和中美洲牛診斷市場細分
南美洲和中美洲牛診斷市場按產品、疾病類型、最終用戶和國家細分。
根據產品,南美洲和中美洲牛診斷市場分為免疫測定試劑盒、PCR 試劑和試劑盒、血凝抑制 (HI) 測定和其他產品。 2022 年,免疫分析試劑盒細分市場在南美洲和中美洲牛診斷市場中佔據最大佔有率。
根據疾病類型,南美洲和中美洲牛診斷市場分為牛病毒性腹瀉(BVD)、牛結核病(TB)、牛乳房炎、口蹄疫(FMD)和其他疾病類型。 2022 年,牛乳房炎細分市場在南美洲和中美洲牛診斷市場中佔據最大佔有率。
根據最終用戶,南美洲和中美洲牛診斷市場分為獸醫醫院、獸醫診所和其他最終用戶。 2022 年,獸醫院細分市場在南美洲和中美洲牛隻診斷市場中佔據最大佔有率。
根據國家/地區,南美洲和中美洲牛診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年,巴西將主導南美洲和中美洲牛隻診斷市場。
Idexx Laboratories Inc、bioMerieux SA、Innovative Diagnostics SAS、Neogen Corp 和 Thermo Fisher Scientific Inc 是南美洲和中美洲牛診斷市場的一些領先公司。
The South & Central America bovine diagnostics market is expected to grow from US$ 114.01 million in 2022 to US$ 179.57 million by 2030. It is estimated to grow at a CAGR of 5.8% from 2022 to 2030.
High Prevalence and Economic Impact of Bovine Mastitis Fuels South & Central America Bovine Diagnostics Market
Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion.
According to the study "Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis," published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011-2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.
South & Central America Bovine Diagnostics Market Overview
The bovine diagnostics market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is mainly driven by the factors such as advancements in bovine diagnostics tools and technologies, increasing incidences of foot and mouth diseases and bTB, and a rise in bovine diagnostics to enhance the quality of food products containing bovine meat. Brazil counts for the largest share of the bovine diagnostic market in South & Central America. Brazil is the world's leading livestock country, with the largest number of cattle grown. The growth of the world's population and improvements in living standards boost the demand for meat across the world. Therefore, the demand for healthy meats results in the growth of the bovine diagnostics market in Brazil. Technological progress in diagnostics has enabled the diagnosis and phylogenetic analysis of bovine leukemia virus (BLV). The BLV infection in dairy cattle was evident in Maranhao, Northeastern Brazil, and for the first time in 2022, phylogenetic inferences showed genotype 6 in this region. This genotype is related to gene sequences previously identified in samples from central-western and southeastern Brazil. Thus, the development efforts for BLV and EBL diagnosis were initiated in 2022, which has fueled progress in leukemia treatment options for the cases of infections that are in an early stage. Enzootic bovine leukosis (EBL) is a chronic viral disease widely distributed in cattle herds and may take several years to manifest clinical signs. Thus, to prevent the epidemic in cattle, the diagnosis would allow veterinary health authorities and animal farmers to take preliminary actions.
South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Bovine Diagnostics Market Segmentation
The South & Central America bovine diagnostics market is segmented into product, disease type, end user, and country.
Based on product, the South & Central America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on disease type, the South & Central America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on end user, the South & Central America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on country, the South & Central America bovine diagnostics market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bovine diagnostics market in 2022.
Idexx Laboratories Inc, bioMerieux SA, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America bovine diagnostics market.